ULKI Presents As a Therapeutic Target to Sensitize Resistant Acute Myeloid Leukemia Cells to Venetoclax

被引：0
|
作者：
Betz, Heather [1 ,2 ]
Jiang, Xiaoyan [1 ,2 ]
机构：
[1] BC Canc Res Ctr, Terry Fox Lab, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Med, Vancouver, BC, Canada
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-206028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2776 / 2776
页数：1
相关论文
共 50 条
  • [1] APOC2 Is Upregulated in Acute Myeloid Leukemia and Presents a Novel Therapeutic Target
    Zhang, Tian
    Vaikari, Vijaya Pooja
    Wu, Sharon
    Loza, Donna Alexandra
    Akhtari, Mojtaba
    Alachkar, Houda
    BLOOD, 2017, 130
  • [2] Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax
    Culp-Hill, Rachel
    Stevens, Brett M.
    Jones, Courtney L.
    Pei, Shanshan
    Dzieciatkowska, Monika
    Minhajuddin, Mohammad
    Jordan, Craig T.
    D'Alessandro, Angelo
    METABOLITES, 2023, 13 (04)
  • [3] Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine
    Nishi, Rie
    Shigemi, Hiroko
    Negoro, Eiju
    Okura, Miyuki
    Hosono, Naoko
    Yamauchi, Takahiro
    BMC CANCER, 2020, 20 (01)
  • [4] Homoharringtonine sensitized resistant acute myeloid leukemia cells to venetoclax-induced apoptosis
    Yin, Zhao
    Gao, Ya
    Bu, Xiaoyin
    Wang, Junhui
    Yao, Zurong
    Liu, Qifa
    Zhang, Yu
    Yu, Guopan
    Ping, Baohong
    LEUKEMIA & LYMPHOMA, 2024, 65 (14) : 2138 - 2150
  • [5] Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine
    Rie Nishi
    Hiroko Shigemi
    Eiju Negoro
    Miyuki Okura
    Naoko Hosono
    Takahiro Yamauchi
    BMC Cancer, 20
  • [6] Resistance mechanisms and therapeutic strategies for venetoclax in acute myeloid leukemia
    Wei, Andrew H.
    CANCER SCIENCE, 2025, 116 : 138 - 138
  • [7] Utility of therapeutic drug monitoring of venetoclax in acute myeloid leukemia
    Masayuki Kobayashi
    Takeo Yasu
    Ken Suzaki
    Nobuharu Kosugi
    Medical Oncology, 39
  • [8] Utility of therapeutic drug monitoring of venetoclax in acute myeloid leukemia
    Kobayashi, Masayuki
    Yasu, Takeo
    Suzaki, Ken
    Kosugi, Nobuharu
    MEDICAL ONCOLOGY, 2022, 39 (12)
  • [9] Venetoclax in acute myeloid leukemia
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (04) : 271 - 276
  • [10] Venetoclax in Acute Myeloid Leukemia
    Mihaila, Romeo G.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (01) : 11 - 28
12345